SCHEMBL8868529

SCHEMBL8868529

Cc1ccccc1C(=O)OCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)c3ccc(Cl)cc3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.49
FLT1 P17948 2/20 0.47
FLT4 P35916 2/20 0.47
KDR P35968 2/20 0.47
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
P4HTM Q9NXG6 1/20 0.44
EGFR P00533 1/20 0.44
BCL2L1 Q07817 1/20 0.44
MCL1 Q07820 1/20 0.44
NAMPT P43490 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 3/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 1/20 0.41
NLRP3 Q96P20 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868704 0.95 P4HTM (0.48) PPARANPC1RAB9AP4HTMSMN1; SMN2
SCHEMBL8868009 0.92 P4HTM (0.46) PPARAFLT1FLT4KDRNPC1
SCHEMBL7870556 0.91 PPARA (0.46) PPARAFLT1FLT4KDRNPC1
SCHEMBL8867585 0.90 NLRP3 (0.57) MAPTLMNANLRP3CYP3A4CYP2C9
SCHEMBL8870501 0.89 P4HTM (0.43) PPARAFLT1FLT4KDRNPC1
SCHEMBL8868612 0.89 P4HTM (0.45) PPARANPC1RAB9AP4HTMSMN1; SMN2
SCHEMBL8870423 0.87 LMNA (0.48) PPARAP4HTMSMN1; SMN2MAPTLMNA
SCHEMBL8869128 0.87 PPARA (0.50) PPARAFLT1FLT4KDRNPC1
SCHEMBL8869577 0.86 EGFR (0.53) PPARAFLT1FLT4KDRNPC1
SCHEMBL8869604 0.86 EGFR (0.53) PPARAFLT1FLT4KDRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed